Herbeck-Belnap, Birgit

[["dc.bibliographiccitation.firstpage","495"],["dc.bibliographiccitation.issue","6"],["dc.bibliographiccitation.journal","Psychosomatic Medicine"],["dc.bibliographiccitation.lastpage","505"],["dc.bibliographiccitation.volume","81"],["dc.contributor.author","Herbeck Belnap, Bea"],["dc.contributor.author","Anderson, Amy"],["dc.contributor.author","Abebe, Kaleab Z."],["dc.contributor.author","Ramani, Ravi"],["dc.contributor.author","Muldoon, Matthew F."],["dc.contributor.author","Karp, Jordan F."],["dc.contributor.author","Rollman, Bruce L."],["dc.date.accessioned","2020-12-10T18:20:10Z"],["dc.date.available","2020-12-10T18:20:10Z"],["dc.date.issued","2019"],["dc.identifier.doi","10.1097/PSY.0000000000000706"],["dc.identifier.issn","0033-3174"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/75475"],["dc.language.iso","en"],["dc.notes.intern","DOI Import GROB-354"],["dc.title","Blended Collaborative Care to Treat Heart Failure and Comorbid Depression"],["dc.title.alternative","Rationale and Study Design of the Hopeful Heart Trial"],["dc.type","journal_article"],["dc.type.internalPublication","yes"],["dspace.entity.type","Publication"]]

[["dc.bibliographiccitation.issue","4"],["dc.bibliographiccitation.journal","Psychosomatic Medicine"],["dc.bibliographiccitation.volume","79"],["dc.contributor.author","Chavanon, Mira-Lynn"],["dc.contributor.author","Belnap, Birgit H."],["dc.contributor.author","Meyer, Thomas"],["dc.contributor.author","Abebe, Kaleab Z."],["dc.contributor.author","Herrmann-Lingen, Christoph"],["dc.contributor.author","Rollman, Bruce L."],["dc.date.accessioned","2018-11-07T10:24:24Z"],["dc.date.available","2018-11-07T10:24:24Z"],["dc.date.issued","2017"],["dc.format.extent","A26"],["dc.identifier.isi","000401250500065"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/42654"],["dc.notes.status","zu prüfen"],["dc.notes.submitter","PUB_WoS_Import"],["dc.publisher","Lippincott Williams & Wilkins"],["dc.publisher.place","Philadelphia"],["dc.relation.conference","75th Annual Scientific Meeting on Mobilizing Technology to Advance Biobehavioral Science and Health"],["dc.relation.eventlocation","Sevilla, SPAIN"],["dc.relation.issn","1534-7796"],["dc.relation.issn","0033-3174"],["dc.title","EMOTION REGULATION IN PATIENTS WITH CHRONIC HEART FAILURE: RELATIONSHIP TO DEPRESSIVE SYMPTOMS"],["dc.type","conference_abstract"],["dc.type.internalPublication","yes"],["dc.type.peerReviewed","yes"],["dc.type.status","published"],["dspace.entity.type","Publication"]]

[["dc.bibliographiccitation.firstpage","9"],["dc.bibliographiccitation.journal","General Hospital Psychiatry"],["dc.bibliographiccitation.lastpage","14"],["dc.bibliographiccitation.volume","42"],["dc.contributor.author","Deveney, Tatiana K."],["dc.contributor.author","Belnap, Bea Herbeck"],["dc.contributor.author","Mazumdar, Sati"],["dc.contributor.author","Rollman, Bruce L."],["dc.date.accessioned","2018-11-07T10:09:25Z"],["dc.date.available","2018-11-07T10:09:25Z"],["dc.date.issued","2016"],["dc.description.abstract","Objective: An American Heart Association (AHA) Science Advisory recommends patients with coronary heart disease undergo routine screening for depressive symptoms with the two-stage Patient Health Questionnaire (PHQ). However, little is known on the prognostic impact of a positive PHQ screen on heart failure (HF) mortality. Methods: We screened hospitalized patients with systolic HF (left ventricle ejection fraction <= 40%) for depression with the two-item Patient Health Questionnaire (PHQ-2) and administered the follow-up nine-item Patient Health Questionnaire (PHQ-9) both immediately following the PHQ-2 and by telephone 1month after discharge. Later, we ascertained vital status at 4-year follow-up on all patients who completed the inpatient PHQ-9 and calculated mortality incidence and risk by baseline PHQ. Results: Of the 520 HF patients we enrolled, 371 screened positive for depressive symptoms on the PHQ-2. Of these, 63% scored PHQ-9 >= 10 versus 24% of those who completed the PHQ-9 1 month later (P < .001). PHQ-2 positive status was an independent predictor of 4-year all-cause mortality (HR: 1.50; P =. 04), and mortality incidence was similar by baseline PHQ-9 score. Conclusions: Among hospitalized patients with systolic HF, a positive PHQ-2 screen for depressive symptoms is an independent risk factor for increased 4-year all-cause mortality. Our findings extend the AHA's Science Advisory for depression to hospitalized patients with systolic HF. (C) 2016 Elsevier Inc. All rights reserved."],["dc.identifier.doi","10.1016/j.genhosppsych.2016.06.005"],["dc.identifier.isi","000384140700003"],["dc.identifier.pmid","27638965"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/39645"],["dc.notes.status","zu prüfen"],["dc.notes.submitter","Najko"],["dc.publisher","Elsevier Science Inc"],["dc.relation.issn","1873-7714"],["dc.relation.issn","0163-8343"],["dc.title","The prognostic impact and optimal timing of the Patient Health Questionnaire depression screen on 4-year mortality among hospitalized patients with systolic heart failure"],["dc.type","journal_article"],["dc.type.internalPublication","yes"],["dc.type.peerReviewed","yes"],["dc.type.status","published"],["dspace.entity.type","Publication"]]

[["dc.bibliographiccitation.firstpage","490"],["dc.bibliographiccitation.issue","2"],["dc.bibliographiccitation.journal","Journal of General Internal Medicine"],["dc.bibliographiccitation.lastpage","497"],["dc.bibliographiccitation.volume","35"],["dc.contributor.author","Jonassaint, Charles R."],["dc.contributor.author","Belnap, Bea Herbeck"],["dc.contributor.author","Huang, Yan"],["dc.contributor.author","Karp, Jordan F."],["dc.contributor.author","Abebe, Kaleab Z."],["dc.contributor.author","Rollman, Bruce L."],["dc.date.accessioned","2020-12-10T14:13:30Z"],["dc.date.available","2020-12-10T14:13:30Z"],["dc.date.issued","2019"],["dc.identifier.doi","10.1007/s11606-019-05542-1"],["dc.identifier.eissn","1525-1497"],["dc.identifier.issn","0884-8734"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/71292"],["dc.language.iso","en"],["dc.notes.intern","DOI Import GROB-354"],["dc.title","Racial Differences in the Effectiveness of Internet-Delivered Mental Health Care"],["dc.type","journal_article"],["dc.type.internalPublication","yes"],["dspace.entity.type","Publication"]]

[["dc.bibliographiccitation.firstpage","28"],["dc.bibliographiccitation.issue","1"],["dc.bibliographiccitation.journal","Journal of Psychosomatic Research"],["dc.bibliographiccitation.lastpage","33"],["dc.bibliographiccitation.volume","76"],["dc.contributor.author","Meyer, Thomas"],["dc.contributor.author","Belnap, Bea Herbeck"],["dc.contributor.author","Herrmann-Lingen, Christoph"],["dc.contributor.author","He, Fanyin"],["dc.contributor.author","Mazumdar, Sati"],["dc.contributor.author","Rollman, Bruce L."],["dc.date.accessioned","2018-11-07T09:46:53Z"],["dc.date.available","2018-11-07T09:46:53Z"],["dc.date.issued","2014"],["dc.description.abstract","Objective: To determine whether the use and adjustment of antidepressant pharmacotherapy accounted for the beneficial effects of collaborative care treatment on the improvement of mood symptoms and health-related quality of life (HRQoL) after coronary artery bypass graft (CABG) surgery. Methods: In a post-hoc analysis of data from the Bypassing the Blues (BtB) trial we tested the impact of antidepressant medication on changes in depression and HRQoL from the early postoperative period to 8-month follow-up. Two hundred fifty-nine depressed post-CABG patients scoring >= 10 on the Patient Health Questionnaire-9 were classified in four groups according to whether or not they received antidepressants at baseline and 8-months following randomization. Results: Patients using antidepressant pharmacotherapy at baseline and follow-up tended to be younger and female (p <= 0.01), but were similar in various clinical characteristics. Just 24% (63/259) of patients were on an antidepressant at baseline which increased to 36% at follow-up (94/259). Compared to other groups, patients on antidepressants at both baseline and follow-up assessment showed the smallest improvement in mood symptoms and HRQoL. While multivariate analyses confirmed that randomization to collaborative care was associated with greater improvement in mood symptoms (odds ratio [OR] = 3.1; 95%-confidence interval [CI] = 1.8-5.4, p<0.0001) and mental HRQoL (OR = 3.6, Cl = 1.4-93, p = 0.01), use of antidepressant medication had no differential impact on either measure (p = 0.06 and p = 0.92, respectively). Conclusion: The beneficial effects of collaborative care for post-CABG depression were not generated by adjustments in antidepressant medication. (C) 2013 Elsevier Inc. All rights reserved."],["dc.identifier.doi","10.1016/j.jpsychores.2013.10.017"],["dc.identifier.isi","000329591800006"],["dc.identifier.pmid","24360138"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/34989"],["dc.notes.status","zu prüfen"],["dc.notes.submitter","Najko"],["dc.publisher","Pergamon-elsevier Science Ltd"],["dc.relation.issn","1879-1360"],["dc.relation.issn","0022-3999"],["dc.title","Benefits of collaborative care for post-CABG depression are not related to adjustments in antidepressant pharmacotherapy"],["dc.type","journal_article"],["dc.type.internalPublication","yes"],["dc.type.peerReviewed","yes"],["dc.type.status","published"],["dspace.entity.type","Publication"]]